| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.003 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.004 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.004 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.004 |